Insurance - Life
Compare Stocks
2 / 10Stock Comparison
CNO vs GL
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Life
CNO vs GL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Life | Insurance - Life |
| Market Cap | $4.28B | $12.11B |
| Revenue (TTM) | $4.49B | $6.00B |
| Net Income (TTM) | $222M | $1.16B |
| Gross Margin | 40.2% | 33.4% |
| Operating Margin | 6.3% | 24.4% |
| Forward P/E | 10.4x | 9.9x |
| Total Debt | $4.05B | $2.63B |
| Cash & Equiv. | $956M | $145M |
CNO vs GL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CNO Financial Group… (CNO) | 100 | 318.5 | +218.5% |
| Globe Life Inc. (GL) | 100 | 200.5 | +100.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNO vs GL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNO is the clearest fit if your priority is dividends.
- 1.5% yield, 13-year raise streak, vs GL's 0.7%
GL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 23 yrs, beta 0.48, yield 0.7%
- Rev growth 3.8%, EPS growth 17.8%, 3Y rev CAGR 4.7%
- 179.3% 10Y total return vs CNO's 170.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.8% revenue growth vs CNO's 0.9% | |
| Value | Lower P/E (9.9x vs 10.4x), PEG 0.64 vs 4.78 | |
| Quality / Margins | Combined ratio 0.8 vs CNO's 0.9 (lower = better underwriting) | |
| Stability / Safety | Beta 0.48 vs CNO's 0.80, lower leverage | |
| Dividends | 1.5% yield, 13-year raise streak, vs GL's 0.7% | |
| Momentum (1Y) | +29.2% vs CNO's +23.8% | |
| Efficiency (ROA) | 3.8% ROA vs CNO's 0.6%, ROIC 13.4% vs 4.0% |
CNO vs GL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNO vs GL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GL and CNO operate at a comparable scale, with $6.0B and $4.5B in trailing revenue. GL is the more profitable business, keeping 19.4% of every revenue dollar as net income compared to CNO's 4.9%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.5B | $6.0B |
| EBITDAEarnings before interest/tax | $573M | $1.6B |
| Net IncomeAfter-tax profit | $222M | $1.2B |
| Free Cash FlowCash after capex | $676M | $1.3B |
| Gross MarginGross profit ÷ Revenue | +40.2% | +33.4% |
| Operating MarginEBIT ÷ Revenue | +6.3% | +24.4% |
| Net MarginNet income ÷ Revenue | +4.9% | +19.4% |
| FCF MarginFCF ÷ Revenue | +15.1% | +20.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.2% | +3.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -39.2% | +9.3% |
Valuation Metrics
GL leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.0x trailing earnings, GL trades at a 44% valuation discount to CNO's 19.5x P/E. Adjusting for growth (PEG ratio), GL offers better value at 0.71x vs CNO's 8.93x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.3B | $12.1B |
| Enterprise ValueMkt cap + debt − cash | $7.4B | $14.6B |
| Trailing P/EPrice ÷ TTM EPS | 19.45x | 10.98x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.41x | 9.93x |
| PEG RatioP/E ÷ EPS growth rate | 8.93x | 0.71x |
| EV / EBITDAEnterprise value multiple | 14.08x | 9.17x |
| Price / SalesMarket cap ÷ Revenue | 0.95x | 2.02x |
| Price / BookPrice ÷ Book value/share | 1.69x | 2.09x |
| Price / FCFMarket cap ÷ FCF | 6.34x | 9.66x |
Profitability & Efficiency
GL leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
GL delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $9 for CNO. GL carries lower financial leverage with a 0.44x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNO's 1.54x. On the Piotroski fundamental quality scale (0–9), GL scores 8/9 vs CNO's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.6% | +20.6% |
| ROA (TTM)Return on assets | +0.6% | +3.8% |
| ROICReturn on invested capital | +4.0% | +13.4% |
| ROCEReturn on capital employed | +1.5% | +5.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 |
| Debt / EquityFinancial leverage | 1.54x | 0.44x |
| Net DebtTotal debt minus cash | $3.1B | $2.5B |
| Cash & Equiv.Liquid assets | $956M | $145M |
| Total DebtShort + long-term debt | $4.1B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 2.23x | 11.27x |
Total Returns (Dividends Reinvested)
Evenly matched — CNO and GL each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CNO five years ago would be worth $18,101 today (with dividends reinvested), compared to $14,968 for GL. Over the past 12 months, GL leads with a +29.2% total return vs CNO's +23.8%. The 3-year compound annual growth rate (CAGR) favors CNO at 30.0% vs GL's 13.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +8.7% | +12.0% |
| 1-Year ReturnPast 12 months | +23.8% | +29.2% |
| 3-Year ReturnCumulative with dividends | +119.7% | +45.4% |
| 5-Year ReturnCumulative with dividends | +81.0% | +49.7% |
| 10-Year ReturnCumulative with dividends | +170.9% | +179.3% |
| CAGR (3Y)Annualised 3-year return | +30.0% | +13.3% |
Risk & Volatility
Evenly matched — CNO and GL each lead in 1 of 2 comparable metrics.
Risk & Volatility
GL is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than CNO's 0.80 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 0.48x |
| 52-Week HighHighest price in past year | $46.19 | $156.69 |
| 52-Week LowLowest price in past year | $35.24 | $116.73 |
| % of 52W HighCurrent price vs 52-week peak | +99.0% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 72.0 | 66.6 |
| Avg Volume (50D)Average daily shares traded | 558K | 452K |
Analyst Outlook
Evenly matched — CNO and GL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates CNO as "Hold" and GL as "Hold". Consensus price targets imply 10.9% upside for GL (target: $171) vs 2.1% for CNO (target: $47). For income investors, CNO offers the higher dividend yield at 1.48% vs GL's 0.69%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $46.67 | $171.25 |
| # AnalystsCovering analysts | 17 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +0.7% |
| Dividend StreakConsecutive years of raises | 13 | 23 |
| Dividend / ShareAnnual DPS | $0.68 | $1.06 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.7% | +7.3% |
GL leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 3 categories are tied.
CNO vs GL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CNO or GL a better buy right now?
For growth investors, Globe Life Inc.
(GL) is the stronger pick with 3. 8% revenue growth year-over-year, versus 0. 9% for CNO Financial Group, Inc. (CNO). Globe Life Inc. (GL) offers the better valuation at 11. 0x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate CNO Financial Group, Inc. (CNO) a "Hold" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNO or GL?
On trailing P/E, Globe Life Inc.
(GL) is the cheapest at 11. 0x versus CNO Financial Group, Inc. at 19. 5x. On forward P/E, Globe Life Inc. is actually cheaper at 9. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Globe Life Inc. wins at 0. 64x versus CNO Financial Group, Inc. 's 4. 78x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CNO or GL?
Over the past 5 years, CNO Financial Group, Inc.
(CNO) delivered a total return of +81. 0%, compared to +49. 7% for Globe Life Inc. (GL). Over 10 years, the gap is even starker: GL returned +179. 3% versus CNO's +170. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNO or GL?
By beta (market sensitivity over 5 years), Globe Life Inc.
(GL) is the lower-risk stock at 0. 48β versus CNO Financial Group, Inc. 's 0. 80β — meaning CNO is approximately 67% more volatile than GL relative to the S&P 500. On balance sheet safety, Globe Life Inc. (GL) carries a lower debt/equity ratio of 44% versus 154% for CNO Financial Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNO or GL?
By revenue growth (latest reported year), Globe Life Inc.
(GL) is pulling ahead at 3. 8% versus 0. 9% for CNO Financial Group, Inc. (CNO). On earnings-per-share growth, the picture is similar: Globe Life Inc. grew EPS 17. 8% year-over-year, compared to -37. 2% for CNO Financial Group, Inc.. Over a 3-year CAGR, CNO leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNO or GL?
Globe Life Inc.
(GL) is the more profitable company, earning 19. 4% net margin versus 5. 1% for CNO Financial Group, Inc. — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GL leads at 24. 4% versus 6. 5% for CNO. At the gross margin level — before operating expenses — CNO leads at 44. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNO or GL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Globe Life Inc. (GL) is the more undervalued stock at a PEG of 0. 64x versus CNO Financial Group, Inc. 's 4. 78x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Globe Life Inc. (GL) trades at 9. 9x forward P/E versus 10. 4x for CNO Financial Group, Inc. — 0. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GL: 10. 9% to $171. 25.
08Which pays a better dividend — CNO or GL?
All stocks in this comparison pay dividends.
CNO Financial Group, Inc. (CNO) offers the highest yield at 1. 5%, versus 0. 7% for Globe Life Inc. (GL).
09Is CNO or GL better for a retirement portfolio?
For long-horizon retirement investors, Globe Life Inc.
(GL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 0. 7% yield, +179. 3% 10Y return). Both have compounded well over 10 years (GL: +179. 3%, CNO: +170. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNO and GL?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CNO is a small-cap quality compounder stock; GL is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.